Opthea Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Opthea Ltd: Opthea Welcomes Retina Leaders to its Medical Advisory Board
Opthea Ltd: Security Class Reinstatement to Quotation- OPTOB
Opthea Ltd: OPTOB Top Holders
Opthea Ltd: OPTOB - Range of Units
Opthea Ltd: Security Class Suspension from Quotation OPTOB
Opthea Ltd: Opthea Announces Publication on VEGF- C and D
Opthea Ltd: Trading Halt - Accelerated Offer
Opthea Ltd: Trading Halt
Opthea Ltd: Opthea to Present at Clinical Trials at the Summit Meeting
Opthea Ltd: Opthea Completes Enrollment in Phase 3 Clinical Program
Opthea Ltd: Opthea Announces Presentations at Retina World Congress
Opthea Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Opthea Ltd: Opthea Presents at the OIS Retina Innovation Summit at ARVO
Opthea Ltd: Opthea Appoints John Han, PharmD, as VP Medical Affairs
Opthea Ltd: Opteha to Participate in the 23rd Needham Virtual Conference
Opthea Ltd: Final Director's Interest Notice DS
Opthea Ltd: Initial Director's Interest Notice Sujal Shah
Opthea Ltd: Opthea to Host Key Opinion Leader Event on April 3, 2024
Opthea Ltd: Opthea to Participate in Leerink Global Biopharma Conference
No Data